88 related articles for article (PubMed ID: 21819329)
1. [Not Available].
Eriksen DO; Pape M; Petersen LK; Larsen CS; Møller BK; Hammer A
Ugeskr Laeger; 2023 Jul; 185(28):. PubMed ID: 37539796
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic HPV vaccines.
Hancock G; Hellner K; Dorrell L
Best Pract Res Clin Obstet Gynaecol; 2018 Feb; 47():59-72. PubMed ID: 29108943
[TBL] [Abstract][Full Text] [Related]
3. Early direct and indirect impact of quadrivalent HPV (4HPV) vaccine on genital warts: a systematic review.
Mariani L; Vici P; Suligoi B; Checcucci-Lisi G; Drury R
Adv Ther; 2015 Jan; 32(1):10-30. PubMed ID: 25620536
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus vaccination: current indications and future directions.
Gattoc L; Nair N; Ault K
Obstet Gynecol Clin North Am; 2013 Jun; 40(2):177-97. PubMed ID: 23732024
[TBL] [Abstract][Full Text] [Related]
5. Advances in Designing and Developing Vaccines, Drugs and Therapeutic Approaches to Counter Human Papilloma Virus.
Dadar M; Chakraborty S; Dhama K; Prasad M; Khandia R; Hassan S; Munjal A; Tiwari R; Karthik K; Kumar D; Iqbal HMN; Chaicumpa W
Front Immunol; 2018; 9():2478. PubMed ID: 30483247
[TBL] [Abstract][Full Text] [Related]
6. Strategies for fostering HPV vaccine acceptance.
Gonik B
Infect Dis Obstet Gynecol; 2006; 2006 Suppl():36797. PubMed ID: 16967911
[TBL] [Abstract][Full Text] [Related]
7. Novel Approaches for Vaccination Against HPV-Induced Cancers.
King E; Ottensmeier C; Pollock KGJ
Curr Top Microbiol Immunol; 2017; 405():33-53. PubMed ID: 25735921
[TBL] [Abstract][Full Text] [Related]
8. Breaking the silence: the taboo surrounding HPV vaccination in Morocco.
Kouhen F; El Ghanmi A
Int J Gynecol Cancer; 2023 Nov; 33(11):1835. PubMed ID: 37813478
[No Abstract] [Full Text] [Related]
9. Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis.
Malagón T; Drolet M; Boily MC; Franco EL; Jit M; Brisson J; Brisson M
Lancet Infect Dis; 2012 Oct; 12(10):781-9. PubMed ID: 22920953
[TBL] [Abstract][Full Text] [Related]
10. The distribution and pathogenic risk of non-9-valent vaccine covered HPV subtypes in cervical lesions.
Ma M; Zhu J; Yang Y; Wang X; Jin Y; Zhang J; Wu S
Cancer Med; 2022 Mar; 11(6):1542-1552. PubMed ID: 34981653
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by region.
Castellsagué X; Ault KA; Bosch FX; Brown D; Cuzick J; Ferris DG; Joura EA; Garland SM; Giuliano AR; Hernandez-Avila M; Huh W; Iversen OE; Kjaer SK; Luna J; Monsonego J; Muñoz N; Myers E; Paavonen J; Pitisuttihum P; Steben M; Wheeler CM; Perez G; Saah A; Luxembourg A; Sings HL; Velicer C
Papillomavirus Res; 2016 Dec; 2():61-69. PubMed ID: 29074187
[TBL] [Abstract][Full Text] [Related]
12. Ten years of anti-HPV vaccinations: what do we know?
Jach R; Basta A; Kotarski J; Markowska J; Paszkowski T; Dębski R; Rokita W; Kędzia W; Kiszka K
Prz Menopauzalny; 2016 Nov; 15(3):170-175. PubMed ID: 27980529
[TBL] [Abstract][Full Text] [Related]
13. Human papilloma virus vaccination: impact and recommendations across the world.
Bonanni P; Bechini A; Donato R; Capei R; Sacco C; Levi M; Boccalini S
Ther Adv Vaccines; 2015 Jan; 3(1):3-12. PubMed ID: 25553242
[TBL] [Abstract][Full Text] [Related]
14. Squamous papilloma in the external auditory canal: A common lesion in an uncommon site.
Chang NC; Chien CY; Wu CC; Chai CY
World J Clin Cases; 2013 May; 1(2):92-5. PubMed ID: 24303475
[TBL] [Abstract][Full Text] [Related]
15. Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease.
Serrano B; Alemany L; Tous S; Bruni L; Clifford GM; Weiss T; Bosch FX; de Sanjosé S
Infect Agent Cancer; 2012 Dec; 7(1):38. PubMed ID: 23273245
[TBL] [Abstract][Full Text] [Related]
16. Primary prophylactic human papillomavirus vaccination programs: future perspective on global impact.
Brotherton JM; Gertig DM
Expert Rev Anti Infect Ther; 2011 Aug; 9(8):627-39. PubMed ID: 21819329
[TBL] [Abstract][Full Text] [Related]
17. Trends in Genital Warts in the Era of Human Papillomavirus Vaccination.
Calo WA; Brewer NT
Sex Transm Dis; 2015 Dec; 42(12):669-70. PubMed ID: 26560967
[No Abstract] [Full Text] [Related]
18. A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.
Goldstone SE; Vuocolo S
Expert Rev Vaccines; 2012 Apr; 11(4):395-406. PubMed ID: 22551023
[TBL] [Abstract][Full Text] [Related]
19. An update on barriers to adolescent human papillomavirus vaccination in the USA.
Berenson AB
Expert Rev Vaccines; 2015; 14(10):1377-84. PubMed ID: 26292763
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
